UK markets close in 7 hours 56 minutes

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.7988+0.1226 (+18.13%)
At close: 04:00PM EST
0.8093 +0.01 (+1.31%)
After hours: 08:00PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
21,225
41,867
23,028
135,082
Cost of revenue
7,696
7,266
0
0
Gross profit
13,529
34,601
23,028
135,082
Operating expenses
Research development
106,105
91,879
82,701
107,851
Selling general and administrative
27,496
30,129
29,285
21,749
Total operating expenses
133,724
122,136
112,111
129,697
Operating income or loss
-120,195
-87,535
-89,083
5,385
Total other income/expenses net
3,680
2,061
642
2,334
Income before tax
-116,515
-85,474
-88,441
7,719
Income tax expense
-
0
0
-691
Income from continuing operations
-116,515
-85,474
-88,441
8,410
Net income
-116,515
-85,474
-88,441
8,410
Net income available to common shareholders
-116,515
-85,474
-88,441
8,410
Basic EPS
-2.15
-1.59
-1.74
0.18
Diluted EPS
-2.15
-1.59
-1.74
0.18
Basic average shares
53,970
53,654
50,719
47,413
Diluted average shares
53,970
53,654
50,719
47,915